Promoting the Latest in Hematology Research 

ASH continues to be a leader in promoting hematology research through over 1,600 articles published in its seven peer-reviewed Blood journals and a record number of abstracts presented at the annual meeting.

By the Numbers

66th ASH Annual Meeting and Exposition

30,000+

Attendees

8,500+

Abstracts Received

5,000+

Abstracts Presented

Expanding the Blood Journals Portfolio

ASH expanded the Blood journals portfolio with the launch of three new journals, Blood Global Hematology, Blood Red Cells & Iron (RCI), and Blood Immunology & Cellular Therapy (ICT). Patrick Gallagher, MD, professor of pediatrics at The Ohio State University, serves as the inaugural editor-in-chief of Blood RCI and Willem Fibbe, MD, emeritus professor of hematology at Leiden University Medical Centre in the Netherlands, is the inaugural editor-in-chief of Blood ICT. These peer-reviewed, open access journals publish high-quality, original research in their specialized areas.

Blood ICT

Blood ICT  covers cellular and non-cellular immunotherapies for hematologic conditions as well as the underlying immunology, including research on monoclonal antibodies, CAR T cells, and gene therapies.
Learn more

Blood RCI

Blood RCI focuses on red blood cells and features research in areas such as inherited and acquired anemias, sickle cell disease, and cell production.
Learn more

Blood Global Hematology

Blood Global Hematology publishes articles describing basic laboratory, translational, and clinical investigations in hematology research that address issues of global reach or with a global focus.
Learn more

Bringing Data and Research to Life

The ASH Research Collaborative (ASH RC) strives to improve the lives of people affected by blood disorders through real-world data and collaborative partnerships. The ASH RC announced the launch of the Real-World Evidence Consortium in partnership with the Reagan-Udall Foundation, published some of the first studies validating the data within the Sickle Cell Disease (SCD) and Multiple Myeloma (MM) Data Hub programs, and presented data at the ASH annual meeting.

Researchers with the MM Research Network presented data on the COVID-19 OutcomeS in Myeloma and the Impact of VaCcines (COSMIC) study, which provides a proof-of-concept model for prospective evidence generation for the myeloma community that encompasses more than 20,000 patient data sets submitted by its 12 U.S.-based academic medical centers. Studies found that researchers could validate an SCD diagnosis through the Data Hub and that disease-modifying therapies remain underused. These studies are just the first of many more to come.

Providing Resources to Hematologists

ASH Clinical News

In 2024, ASH Clinical News celebrated its 10th year. With Aaron Gerds, MD, at the helm as editor-in-chief, ASH Clinical News published 14 annual issues. The magazine received two editorial awards in 2024: an APEX Award for a feature article on culturally sensitive care, and a Communicator Award for an Editor’s Corner by Associate Editor Brea Lipe, MD.
Learn more

The Hematologist

The Hematologist continued to update ASH members about important breakthroughs, clinical trials, and cutting-edge research. Its podcast, with 13 episodes in 2024, highlighted engaging conversations between editors and subject matter experts.
Learn more

ASH Journal Club

The webinar series highlights key papers in hematology published in the Blood journals. In 2024, six webcasts covered a wide array of topics in both classical and malignant hematology.
Learn more

ASH Image Bank

The image bank includes more than 14,000 peer-reviewed images relating to a wide range of hematology topics.
Learn more

ASH Self-Assessment Program

ASH-SAP is a comprehensive resource to help hematologists stay current with the latest advances in both adult and pediatric hematology.
Learn more

How I Treat

This book includes a collection of the top “How I Treat” articles from Blood that are updated to reflect the current standard practice.
Learn more

Explore the ASH 2024 Annual Report